Related references
Note: Only part of the references are listed.A brief measure for assessing generalized anxiety disorder -: The GAD-7
Robert L. Spitzer et al.
ARCHIVES OF INTERNAL MEDICINE (2006)
Infrequent or non-response to oral sumatriptan does not predict response to other triptans -: review of four trials
CGH Dahlöf
CEPHALALGIA (2006)
Almotriptan in migraine patients who respond poorly to oral sumatriptan: A double-blind, randomized trial
HC Diener et al.
HEADACHE (2005)
Triptan nonresponder studies: Implications for clinical practice
DW Dodick
HEADACHE (2005)
Identifying patients who require a change in their current acute migraine treatment: the Migraine Assessment of Current Therapy (Migraine-ACT) questionnaire
AJ Dowson et al.
NEUROLOGICAL SCIENCES (2004)
Eletriptan for the treatment of migraine in patients with previous poor response or tolerance to oral sumatriptan
M Färkkilä et al.
CEPHALALGIA (2003)
Triptans (serotonin, 5-HT1B/1D agonists) in migraine:: detailed results and methods of a meta-analysis of 53 trials
MD Ferrari et al.
CEPHALALGIA (2002)
The PHQ-9 - Validity of a brief depression severity measure
K Kroenke et al.
JOURNAL OF GENERAL INTERNAL MEDICINE (2001)
Pharmacokinetics and pharmacodynamics of the triptan antimigraine agents - A comparative review
SS Jhee et al.
CLINICAL PHARMACOKINETICS (2001)
Practice parameter: Evidence-based guidelines for migraine headache (an evidence-based review) - Report of the Quality Standards Subcommittee of the American Academy of Neurology
SD Silberstein
NEUROLOGY (2000)
Naratriptan efficacy in migraineurs who respond poorly to oral sumatriptan
S Stark et al.
HEADACHE (2000)
Treatment of nonresponders to oral sumatriptan with zolmitriptan and rizatriptan: A comparative open trial
NT Mathew et al.
HEADACHE (2000)
Share Paper
